BATS Chi-X Looks to Exponential-e for Lower Latency

European Union map
BATS Chi-X Europe connects to Exponential-e for ultra-low latency.

BATS Chi-X Europe, the European equities trading, has hooked up to Exponential-e's network providing the exchange with lower latency.

Exponential-e's 100GigE network will provide sub-millisecond market reach to the venue.

"Exponential-e is a welcome addition to our menu of providers," says Mark Hemsley, CEO of BATS Chi-X Europe. "We are pleased that their diverse customer base is well-positioned to connect to BATS Chi-X Europe and to seamlessly access our unique offering of pan-European markets for deep liquidity, product innovation, and efficient post-trade structure."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

If M&A picks up, who’s on the auction block?

Waters Wrap: With projections that mergers and acquisitions are geared to pick back up in 2025, Anthony reads the tea leaves of 25 of this year’s deals to predict which vendors might be most valuable.

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Enough with the ‘Bloomberg Killers’ already

Waters Wrap: Anthony interviews LSEG’s Dean Berry about the Workspace platform, and provides his own thoughts on how that platform and the Terminal have been portrayed over the last few months.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here